Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 16730
Corporate User License Price USD 750
Corporate User License Price INR 50190
Site License Price USD 500
Site License Price INR 33460
Request a Quote

Report Title

Novus Therapeutics Inc (NVUS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Novus Therapeutics Inc (NVUS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Novus Therapeutics Inc (NVUS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Novus Therapeutics Inc (NVUS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile



Executive Summary

Summary

Novus Therapeutics Inc (Tokai Pharma), formerly Tokai Pharmaceuticals Inc is a pharmaceutical company that offers acquisition, development and commercialization of ear, nose and throat ENT products. The company's lead products is a nasally-administer, combination drug product and eustachian tube dysfunction, among others. Its galeterone is an oral small molecule drug candidate with treatment of patients with metastatic castration-resistant prostate cancer. Novus Therapeutics offers OP-02 surfactant program and OP-01 foam platform. Its pipeline also includes androgen receptor degradation agent's drug discovery program to identify and develop compounds for androgen receptor degradation activity. The company has collaboration with pharmaceutical companies to enhance its product candidates. Novus Therapeutics is headquartered in Irvine, California, the US.

Novus Therapeutics Inc (NVUS)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

Business Description-A brief description of the company's operations.

Key Employees-A list of the key executives of the company.

Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

Key Competitors-A list of the key competitors of the company.

Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Novus Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Novus Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 11

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 13

Venture Financing 13

Tokai Pharma Raises USD35.5 Million In Series E Financing 13

Tokai Pharma Raises USD23 Million In Series D3 Financing 15

Partnerships 16

Tokai Pharma Expands Agreement with Qiagen 16

Tokai Pharma Enters into Agreement with Qiagen 17

Licensing Agreements 18

Tokai Pharma Enters into Licensing Agreement with Johns Hopkins University 18

Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore 19

Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore 20

Equity Offering 21

Novus Therapeutics Files Registration Statement to Raise Funds through Public Offering of Shares 21

Tokai Pharma Raises USD0.71 Million in Public Offering of Shares 22

Tokai Pharma Raises USD97.2 Million in IPO 23

Acquisition 25

Tokai Pharma Acquires Otic Pharma 25

Novus Therapeutics Inc-Key Competitors 27

Novus Therapeutics Inc-Key Employees 28

Novus Therapeutics Inc-Locations And Subsidiaries 29

Head Office 29

Recent Developments 30

Financial Announcements 30

Aug 09, 2017: Novus Therapeutics Reports Second Quarter 2017 Results 30

May 10, 2016: Tokai Pharmaceuticals Reports First Quarter 2016 Financial Results 31

Mar 10, 2016: Tokai Pharmaceuticals Reports Full Year 2015 Financial Results 32

Corporate Communications 33

Jun 12, 2017: Novus Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 33

Jul 29, 2016: Tokai Pharmaceuticals Announces Reduction in Force 34

Product News 35

05/18/2016: Tokai Announces Publication of Three Abstracts on Galeterone at the 2016 ASCO Annual Meeting 35

04/13/2016: Tokai Announces Presentations on Galeterone at the AACR Annual Meeting 2016 36

01/08/2016: Tokai Announces Presentation of New Data Highlighting Unique Galeterone Mechanism at ASCO Genitourinary Cancers Symposium 37

Clinical Trials 38

Jul 26, 2016: Tokai Pharmaceuticals Announces Clinical Update 38

Apr 26, 2016: Tokai Announces Oral Presentation on Galeterone at the 2016 AUA Annual Meeting 39

Mar 30, 2016: Tokai Announces Dosing of First Patient in Phase 2 Expansion Study of Galeterone in Enzalutamide-Refractory mCRPC Patients 40

Jan 07, 2016: Tokai Announces Update on ARMOR3-SV and Expanded Galeterone Clinical Development Program 41

Appendix 42

Methodology 42

About GlobalData 42

Contact Us 42

Disclaimer 42

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 7

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9

Novus Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 11

List of Tables

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6

Novus Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8

Novus Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 9

Novus Therapeutics Inc, Medical Devices Deals, 2011 to YTD 2017 11

Novus Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 12

Tokai Pharma Raises USD35.5 Million In Series E Financing 13

Tokai Pharma Raises USD23 Million In Series D3 Financing 15

Tokai Pharma Expands Agreement with Qiagen 16

Tokai Pharma Enters into Agreement with Qiagen 17

Tokai Pharma Enters into Licensing Agreement with Johns Hopkins University 18

Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore 19

Tokai Pharma Amends Licensing Agreement with University of Maryland, Baltimore 20

Novus Therapeutics Files Registration Statement to Raise Funds through Public Offering of Shares 21

Tokai Pharma Raises USD0.71 Million in Public Offering of Shares 22

Tokai Pharma Raises USD97.2 Million in IPO 23

Tokai Pharma Acquires Otic Pharma 25

Novus Therapeutics Inc, Key Competitors 27

Novus Therapeutics Inc, Key Employees 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Novus Therapeutics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand